Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.5.3 was added to the record history and the previous entry v3.5.2 was removed, updating the documented version history on the page. This reflects an archival update to the page's release history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry v3.5.2 was added to the record history and the v3.5.0 entry was removed.SummaryDifference0.1%

- Check30 days agoChange DetectedNew screenshot shows minor visual/layout adjustments to the Record History page; substantive study data and sections remain unchanged.SummaryDifference0.1%

- Check37 days agoChange DetectedA new history version (v39, 2026-03-26) with a Study Status update was added; the 2025-08-06 entry was removed.SummaryDifference0.3%

- Check52 days agoChange DetectedRevision history now includes v3.5.0 as an addition and v3.4.3 as a deletion.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history page adds revision v3.4.3 and removes revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.